Associated Papers
Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M et al.
Frontiers in Endocrinology, 2018
Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma.
Qiu H et al.
Molecular Carcinogenesis, 2017
The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer.
Borriello A et al.
Cell Cycle (georgetown, Tex.), 2015
p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.
Serres MP et al.
The Journal of Clinical Investigation, 2012
RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.
Larrea MD et al.
Proceedings of the National Academy of Sciences of the United States of America, 2009
Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D et al.
Cancer Research, 2008
p27Kip1 localization depends on the tumor suppressor protein tuberin.
Rosner M et al.
Human Molecular Genetics, 2007
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML et al.
The American Journal of Pathology, 2005
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.
Fujita N et al.
The Journal of Biological Chemistry, 2002
Select a paper to view details